Predictors of Sustained Response to Infliximab in Patients With Crohn's Disease: A Single Cohort Study

被引：0
|
作者：
Duricova, Dana
Malickova, Karin
Bortlik, Martin
Machkova, Nadezda
Komarek, Viktor
Bouzkova, Eva
Lukas, Milan
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S593 / S593
页数：1
相关论文
共 50 条
  • [41] Desensitisation to infliximab in patients with Crohn's disease
    Lelong, J
    Duburque, C
    Fournier, C
    Colombel, JF
    Desreumaux, P
    Tonnel, AB
    Wallaert, B
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (02) : 239 - 246
  • [42] Long-term outcome of infliximab maintenance treatment for patients with Crohn's disease: A Japanese single-center cohort study
    Nasuno, Masanao
    Tanaka, Hiroki
    Sugiyama, Kohei
    Miyakawa, Maki
    Motoya, Satoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 466 - 466
  • [43] Predictors of postoperative recurrence in a cohort of Tunisian patients with Crohn's disease
    Hammami, Aya
    Harbi, Raida
    Elleuch, Nour
    Ben Meddeb, Khaled
    Ben Ameur, Wafa
    Dahmani, Wafa
    Braham, Ahlem
    Ajmi, Salem
    Ksiaa, Mehdi
    Ben Slama, Aida
    Jaziri, Hanen
    Jmaa, Ali
    THERAPEUTIC ADVANCES IN GASTROINTESTINAL ENDOSCOPY, 2022, 15
  • [44] Predictors of Sustained Response to Rivastigmine in Patients with Alzheimer's Disease
    Sadowsky, Carl
    Grossberg, George T.
    Somogyi, Monique
    Meng, Xiangyi
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (03): : S120 - S121
  • [45] Genetic predictors of long-term response and trough levels of infliximab in crohn's disease
    Salvador-Martin, Sara
    Lopez-Cauce, Beatriz
    Nunez, Olga
    Laserna-Mendieta, Emilio J.
    Garcia, Maria, I
    Lobato, Elena
    Abarca-Zabalia, Judith
    Sanjurjo-Saez, Maria
    Lucendo, Alfredo J.
    Marin-Jimenez, Ignacio
    Menchen, Luis A.
    Lopez-Fernandez, Luis A.
    PHARMACOLOGICAL RESEARCH, 2019, 149
  • [46] Rapid weight increase in Infliximab treated Crohn's disease patients is sustained over time
    Lepp, J.
    Forsell, A.
    Fyrhake, U.
    Lordal, M.
    Almer, S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S251 - S251
  • [47] Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission
    Reenaers, Catherine
    Mary, Jean-Yves
    Nachury, Maria
    Bouhnik, Yoram
    Laharie, David
    Allez, Matthieu
    Fumery, Mathurin
    Amiot, Aurelien
    Savoye, Guillaume
    Altwegg, Romain
    Devos, Martine
    Malamut, Georgia
    Bourreille, Arnaud
    Flourie, Bernard
    Marteau, Philippe
    Vuitton, Lucine
    Coffin, Benoit
    Viennot, Stephanie
    Lambert, Jerome
    Colombel, Jean-Frederic
    Louis, Edouard
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (02) : 234 - +
  • [48] Population pharmacokinetics of single dose infliximab in patients with Crohn's disease.
    Fasanmade, AA
    Zhu, YW
    Wagner, C
    Pendley, C
    Davis, HM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P66 - P66
  • [49] Response of cutaneous Crohn's disease to infliximab and methotrexate
    Konrad, A
    Seibold, F
    DIGESTIVE AND LIVER DISEASE, 2003, 35 (05) : 351 - 356
  • [50] Predictors of sustained clinical response in patients with Beh‡et's disease-related uveitis treated with infliximab and adalimumab
    Fabiani, Claudia
    Vitale, Antonio
    Rigante, Donato
    Emmi, Giacomo
    Lopalco, Giuseppe
    Sota, Jurgen
    Vannozzi, Lorenzo
    di Scala, Gerardo
    Guerriero, Silvana
    Orlando, Ida
    Franceschini, Rossella
    Capozzoli, Marco
    Frediani, Bruno
    Galeazzi, Mauro
    Iannone, Florenzo
    Tosi, Gian Marco
    Cantarini, Luca
    CLINICAL RHEUMATOLOGY, 2018, 37 (06) : 1715 - 1720
12345